LOS ANGELES - Armata Pharmaceuticals, Inc. (NYSE American:ARMP), a clinical-stage biotechnology company whose stock has surged 54% year-to-date and currently trades at $2.85, announced Monday the ...

Through cutting-edge methods and advanced artificial intelligence analysis, UNC Charlotte researchers leading a ...

Collaborating researchers have made a breakthrough discovery regarding the intricate defense systems of bacteriophages (phages)—viruses that can specifically target harmful bacteria without harming ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that it has ...

Given that phages are able to destroy bacteria, they are of particular interest to science. Basic researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin are ...

Phage therapy is the concept of using viruses (known as phage) to kill bacteria, instead of using antibiotics. Until now, experiments have largely focussed on exposing bacteria to phage in a flask.

But a forgotten treatment, first discovered more than a century ago, could offer hope. Known as bacteriophage therapy—or "phage therapy," for short—it uses viruses that naturally prey on bacteria, ...

Type VI secretion systems are bacterial virulence-associated nanomachines composed of proteins that are evolutionarily related to components of bacteriophage tails. Here we show that protein secretion ...

Lynn Cole was in a never-ending cycle of getting recurrent blood infections. And no antibiotic drugs managed to kill off her zombie-like bacteria. “It just got so frustrating over the years because we ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company advancing a phage bank, the world’s largest therapeutic phage initiative for ...